⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Global Drug Discovery AI Tools Market - Strategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities
globenewswire.com
ABSI
NVDA
RXRX
RLAY
SDGR
UK AI in Drug Discovery Market Size, Share, Trends and Forecast to 2035 | 24.12% CAGR Drives US$ 1.62 Billion Opportunity as Generative AI and SaaS Scale
globenewswire.com
RXRX
Circle Pharma Strengthens Leadership Team with Promotion of Marie Evangelista, Ph.D., to Chief Scientific Officer and Addition of Mary Ellen Sillivos as SVP and Head of Human Resources
businesswire.com
CRSP
RXRX
QTRX
DERM
Global Drug Simulation R&D Platform Market Forecast, 2026-2032 - AI, Cloud Computing and Integrated Modeling Drive 10.59% CAGR, Propelling the Market to USD 6.32 Billion by 2032
globenewswire.com
RXRX
RLAY
AI in Healthcare Market Set for Rapid Expansion Through 2034 as Diagnostics, Personalized Medicine and Automation Drive New Growth Opportunities
globenewswire.com
NVDA
GOOG
MSFT
AMZN
INTC
GEHC
PHG
RXRX
IBM
AI in Life Sciences Market to Reach US$11.52 Billion by 2034 as Drug Discovery, Precision Medicine and Automation Drive New Business Opportunities
globenewswire.com
RXRX
ATOM
NVDA
INTC
AMD
AMZN
MSFT
GOOG
IBM
DELL
ILMN
IQV
ACN
LLY
ORCL
Drug Discovery Platforms Market Set for Growth Through 2033, Fueled by AI-Driven R&D, Precision Medicine and Expanding Therapeutic Applications
globenewswire.com
JNJ
RXRX
Capitalize on AI’s Drug Discovery Disruption: Benchmark NVIDIA, Schrödinger, Recursion, Insilico Medicine and Exscientia to Secure R&D ROI and Competitive Advantage Through 2030
globenewswire.com
NVDA
RXRX
INSM
Form 8-K
sec.gov
RXRX
AI in Genomics Market Set for Transformative Growth Through 2040, Driven by Advanced Technologies, Expanding Applications and Rising Global Adoption
globenewswire.com
ILMN
RXRX
SOPH